Effect of phase i periodontal therapy on anti-cardiolipin antibodies in patients with acute myocardial infarction associated with chronic periodontitis

Journal of Periodontology

Volumn 82, Issue 12, 2011, Pages 1657-1664

  Gunupati, Sumanth ^a   Chava, Vijay K ^a   Krishna, B Phani ^b  

^a NARAYANA DENTAL COLLEGE AND HOSPITAL   (India)

^b NARAYANA MEDICAL COLLEGE   (India)

Author keywords

Antibodies; Anticardiolipin; Cardiovascular diseases; Chronic periodontitis; Enzyme linked immunosorbent assay; Myocardial infarction; Risk factors

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; DENTAL PROPHYLAXIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 82955216209     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110002     Document Type: Article

References (43)

1. Kinane DF, Lowe GD. How periodontal disease may contribute to cardiovascular disease. Periodontol 2000 2000;23:121-126.
2. Friedewald VE, Kornman KS, Beck JD, et al. American Journal of Cardiology; Journal of Periodontology. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol 2009;80:1021-1032.
3. Haynes WG, Stanford C. Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler Thromb Vasc Biol 2003;23:1309-1311. (Pubitemid 36994513)
4. Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol 2001; 6:9-15.
5. Arbes SJ Jr., Slade GD Jr., Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 1999;78:1777-1782. (Pubitemid 32507623)
6. Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G. Antiphospholipid antibodies and the endothelium. Rheum Dis Clin North Am 2001;27:587-602. (Pubitemid 32781417)
7. Karnoutsos K, Papastergiou P, Stefanidis S, Vakaloudi A. Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anticardiolipin antibodies. Hippokratia 2008;12:144-149. (Pubitemid 351962098)
8. Locht H, Wiik A. IgG and IgM isotypes of anticardiolipin and anti-b2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events. Clin Rheumatol 2006;25:246-250. (Pubitemid 43372325)
9. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol 1997; 17:3159-3163. (Pubitemid 28016072)
10. Türkog?lu O, Barisx N, Kütükcxüler N, Senarslan O, Güneri S, Atilla G. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. J Periodontol 2008;79:332-340.
11. Schenkein HA, Berry CR, Burmeister JA, et al. Anticardiolipin antibodies in sera from patients with periodontitis. J Dent Res 2003;82:919-922. (Pubitemid 41756875)
12. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-920. (Pubitemid 46339910)
13. Paquette DW, Brodala N, Nichols TC. Cardiovascular disease, inflammation, and periodontal infection. Periodontol 2000 2007;44:113-126.
14. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
15. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
16. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
17. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-1636. (Pubitemid 32763637)
18. Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol 2002;9: 425-432. (Pubitemid 34226042)
19. Asherson RA, Harris EN. Anticardiolipin antibodies - Clinical associations. Postgrad Med J 1986;62:1081-1087. (Pubitemid 17204456)
20. Ragghianti MS, Greghi SLA, Lauris JRP, Sant'ana ACP, Passanezi E. Influence of age, sex, plaque and smoking on periodontal conditions in a population from Bauru, Brazil. J Appl Oral Sci 2004;12:273-279.
21. Holmlund A, Holm G, Lind L. Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. J Periodontol 2006;77:1173-1178. (Pubitemid 44725023)
22. Cueto A, Mesa F, Bravo M, Ocaña-Riola R. Periodontitis as risk factor for acute myocardial infarction. A case control study of Spanish adults. J Periodontal Res 2005;40:36-42. (Pubitemid 40186624)
23. Desvarieux M, Schwahn C, Völzke H, et al. Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke 2004; 35:2029-2035. (Pubitemid 39129554)
24. Stein JM, Kuch B, Conrads G, et al. Clinical periodontal and microbiologic parameters in patients with acute myocardial infarction. J Periodontol 2009;80: 1581-1589.
25. Rutger Persson G, Ohlsson O, Pettersson T, Renvert S. Chronic periodontitis, a significant relationship with acute myocardial infarction. Eur Heart J 2003;24: 2108-2115. (Pubitemid 37486530)
26. Emingil G, Buduneli E, Aliyev A, Akilli A, Atilla G. Association between periodontal disease and acute myocardial infarction. J Periodontol 2000;71:1882-1886. (Pubitemid 33601025)
27. Dorn JM, Genco RJ, Grossi SG, et al. Periodontal disease and recurrent cardiovascular events in survivors of myocardial infarction (MI): The Western New York Acute MI Study. J Periodontol 2010;81:502-511.
28. Bili A, Moss AJ, Francis CW, Zareba W, Watelet LFM, Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic factors, and recurrent coronary events investigators. Circulation 2000;102:1258-1263.
29. Zuckerman E, Toubi E, Shiran A, et al. Anticardiolipin antibodies and acute myocardial infarction in nonsystemic lupus erythmatosus patients: A controlled prospective study. Am J Med 1996;101:381-386. (Pubitemid 26392855)
30. Sletnes KE, Smith P, Abdelnoor M, Arnesen H, Wisløff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet 1992;339:451-453.
31. Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J 1993;69:391-394. (Pubitemid 23171112)
32. de Godoy JM, de Godoy MF, Braile DM. Recurrent thrombosis in patients with deep vein thrombosis and/ or venous thromboembolism associated with anticardiolipin antibodies. Angiology 2006;57:79-83.
33. Muir KW, Squire IB, Alwan W, Lees KR. Anticardiolipin antibodies in an unselected stroke population. Lancet 1994;344:452-456. (Pubitemid 24248251)
34. Vaarala O, Mänttäri M, Manninen V, et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995;91:23-27.
35. Marai I, Shechter M, Langevitz P, et al. Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am J Cardiol 2008;101:1094-1097.
36. Hussain Bokhari SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M. Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. J Periodontol 2009;80:1574-1580.
37. Cugini MA, Haffajee AD, Smith C, Kent RL Jr., Socransky SS. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results. J Clin Periodontol 2000;27:30-36.
38. Seinost G, Wimmer G, Skerget M, et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 2005;149:1050-1054. (Pubitemid 40848150)
39. Papapanou PN, Sedaghatfar MH, Demmer RT, et al. Periodontal therapy alters gene expression of peripheral blood monocytes. J Clin Periodontol 2007;34: 736-747.
40. Piconi S, Trabattoni D, Luraghi C, et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intimamedia thickness. FASEB J 2009;23:1196-1204.
41. Mercanoglu F, Oflaz H, Oz O, et al. Endothelial dysfunction in patients with chronic periodontitis and its improvement after initial periodontal therapy. J Periodontol 2004;75:1694-1700. (Pubitemid 40260022)
42. Muir KW. Anticardiolipin antibodies and cardiovascular disease. J R Soc Med 1995;88:433-436.
43. Ikonomidis I, Lekakis J, Vamvakou G, et al. Aspirin reduces anticardiolipin antibodies in patients with coronary artery disease. Eur J Clin Invest 2006;36: 839-843. (Pubitemid 44707082)